Thromboembolic Pulmonary Hypertension
📧 Sign up to get email alerts when something new happens for Thromboembolic Pulmonary Hypertension.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2025-12-03EMA Authorised: Adempas (riociguat) — Bayer AG
EMA authorised Adempas (riociguat) by Bayer AG for pulmonary hypertension indications, with a decision dated 06/08/2025.
-
FDA approval · 2020-11-30FDA Approved: ADEMPAS — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approved a supplemental application for ADEMPAS (riociguat) filed by Bayer HealthCare Pharmaceuticals Inc.
-
FDA approval · 2020-02-10FDA Approved: ADEMPAS — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
The FDA approved a supplemental application for ADEMPAS (riociguat) submitted by Bayer HealthCare Pharmaceuticals Inc.
-
FDA approval · 2018-12-06FDA Approved: ADEMPAS — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approved a supplemental application for ADEMPAS (riociguat) filed by Bayer HealthCare Pharmaceuticals Inc.
-
FDA approval · 2018-01-11FDA Approved: ADEMPAS — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approves a supplemental application for ADEMPAS (riociguat) submitted by Bayer HealthCare Pharmaceuticals Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-02-23FDA Approved: ADEMPAS — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approved a supplemental application for ADEMPAS (riociguat) from Bayer HealthCare Pharmaceuticals Inc.
-
FDA approval · 2017-01-17FDA Approved: ADEMPAS — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approved a supplemental application for ADEMPAS (riociguat) from Bayer HealthCare Pharmaceuticals Inc., approving a change to the drug's…
-
FDA approval · 2016-10-04FDA Approved: ADEMPAS — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approved a supplemental application for ADEMPAS (riociguat) submitted by Bayer HealthCare Pharmaceuticals Inc., resulting in an updated …
-
FDA approval · 2015-12-04FDA Approved: ADEMPAS — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
The FDA approved a supplemental application for ADEMPAS (riociguat) from Bayer HealthCare Pharmaceuticals Inc. This action updates the exist…
-
FDA approval · 2015-02-23FDA Approved: ADEMPAS — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approved Bayer HealthCare Pharmaceuticals Inc.'s supplemental application for ADEMPAS (riociguat).
-
FDA approval · 2014-06-11FDA Approved: ADEMPAS — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approved a supplemental application for ADEMPAS (riociguat) from Bayer HealthCare Pharmaceuticals Inc., approving a supplemental submiss…
-
FDA approval · 2014-05-06FDA Approved: ADEMPAS — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approved a supplemental application for ADEMPAS (riociguat) submitted by Bayer HealthCare Pharmaceuticals Inc. The action pertains to th…
-
FDA approval · 2013-10-08FDA Approved: ADEMPAS — Original Application (Bayer HealthCare Pharmaceuticals Inc.)
The FDA approved Adempas (riociguat) from Bayer as the original application for treatment of pulmonary arterial hypertension and chronic thr…